Petlife Pharmaceuticals, Inc.
PTLF · OTC
2/28/2018 | 11/30/2017 | 8/31/2017 | 5/31/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$427 | -$467 | -$1,999 | -$815 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $40 | $76 | $0 | $0 |
| Change in WC | -$1 | $8 | $363 | $53 |
| Other Non-Cash | $226 | $263 | $1,751 | $668 |
| Operating Cash Flow | -$162 | -$120 | $114 | -$94 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $116 | $120 | -$49 | $82 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$12 | $12 |
| Financing Cash Flow | $116 | $120 | -$60 | $94 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$46 | $0 | $54 | -$0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $54 | $54 | $0 | $0 |
| End Cash | $8 | $54 | $54 | $0 |
| Free Cash Flow | -$162 | -$120 | $114 | -$94 |